A new grand bargain to improve the antimicrobial market for human health

  23 September 2023

The working group’s final report highlights the stark disparity in research on policy issues relevant to LMICs when compared with high-income countries (HICs), with less than 10 percent of the academic literature examined focusing on the former group. Different stakeholders have very different policy priorities, with those in HICs more inclined to emphasize the need for innovative new drugs while LMIC policymakers view access as a much greater priority. Countries often think it is not in their interest to implement policies that most agree all countries would benefit from. Global cooperation is needed to overcome collective action problems.

Author(s): Anthony McDonnell, Katherine Klemperer, Morgan Pincombe, Rachel Silverman Bonnifield, Prashant Yadav, and Javier Guzman
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed